Barclays’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,146
| Closed | -$5K | – | 5146 |
|
|
2022
Q1 | $5K | Sell |
3,146
-20,367
| -87% | -$32.4K | ﹤0.01% | 4592 |
|
|
2021
Q4 | $56K | Buy |
23,513
+15,593
| +197% | +$37.1K | ﹤0.01% | 3023 |
|
|
2021
Q3 | $43K | Buy |
7,920
+4,122
| +109% | +$22.4K | ﹤0.01% | 3415 |
|
|
2021
Q2 | $28K | Sell |
3,798
-7,799
| -67% | -$57.5K | ﹤0.01% | 3632 |
|
|
2021
Q1 | $93K | Buy |
11,597
+7,708
| +198% | +$61.8K | ﹤0.01% | 3390 |
|
|
2020
Q4 | $35K | Sell |
3,889
-1,413
| -27% | -$12.7K | ﹤0.01% | 3289 |
|
|
2020
Q3 | $59K | Sell |
5,302
-520
| -9% | -$5.79K | ﹤0.01% | 3220 |
|
|
2020
Q2 | $43K | Buy |
5,822
+2,047
| +54% | +$15.1K | ﹤0.01% | 3443 |
|
|
2020
Q1 | $23K | Sell |
3,775
-7,588
| -67% | -$46.2K | ﹤0.01% | 3358 |
|
|
2019
Q4 | $57K | Buy |
11,363
+8,876
| +357% | +$44.5K | ﹤0.01% | 3565 |
|
|
2019
Q3 | $19K | Sell |
2,487
-765
| -24% | -$5.84K | ﹤0.01% | 3855 |
|
|
2019
Q2 | $38K | Sell |
3,252
-595
| -15% | -$6.95K | ﹤0.01% | 3886 |
|
|
2019
Q1 | $56K | Buy |
+3,847
| New | +$56K | ﹤0.01% | 3607 |
|